Among the most successful fund investment fields, there are Medical, Health Care. Among the most popular portfolio startups of the fund, we may highlight Tivorsan Pharmaceuticals, Prosensa. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.
The typical case for the fund is to invest in rounds with 1 participant. Despite the Parent Project Muscular Dystrophy, startups are often financed by Idinvest Partners, Gimv, Prosensa.
The increased amount of exits for fund were in 2013. Deals in the range of 100 thousands - 1 million dollars are the general things for fund. The high activity for fund was in 2012. The fund is generally included in less than 2 deals every year.
Related Funds
Fund Name | Location |
Antares Capital | Florida, Miami, United States |
AshHill Biomedical | Cincinnati, Ohio, United States |
AWV Partners | - |
Binhai | China, Guangdong, Guangzhou |
Campus Fund | - |
China Life APM Asset Management | Beijing, Beijing, China |
Coherent | California, Santa Clara, United States |
CommonSpirit | - |
Die Wirtschaftskammer | Austria, Vienna |
DST Systems | Kansas City, Missouri, United States |
Formica Ventures | - |
FusionX Ventures | California, San Diego, United States |
Infinity Equity | China, Hong Kong, Hong Kong Island |
Kaedan Capital | Israel, Tel Aviv, Tel Aviv |
Kedaara Capital | India, Maharashtra, Mumbai |
San Diego Venture Partners | - |
Shenzhenshi Huaxia Dexin Jijin Guanli Youxian Gongsi | China, Guangdong Province, Huizhou |
Sunbo Angel Partners | Busan, Pusan-jikhalsi, South Korea |
Yihui Invesment Management | China, Jiangshan, Zhejiang |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Myosana Therapeutics | $5M | 07 Dec 2022 | Seattle, Washington, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Myosana Therapeutics | $5M | 07 Dec 2022 | Seattle, Washington, United States |